KCNH1 and neoplasm: Based on our observation that Kv10.1 is required to maintain mitochondrial stability, we tested the possibility that Kv10.1 inhibition increases the efficacy of antimetabolic drugs, and found a strong increase in the potency of mainly phenformin and VLX-600 in several tumor cell models.